Indian equity markets are likely to see stock-specific action on Friday, January 30, as several companies announced key business updates and quarterly earnings. From real estate acquisitions and renewable energy contracts to Q3 results and management changes, here are the stocks expected to remain in focus today.
Stocks to Watch Today – January 30
Godrej Properties announced the acquisition of an 8.5-acre land parcel in Mahalunge, Pune. The company stated that the project has an estimated revenue potential of ₹2,000 crore.
ACME Solar said one of its arms executed a power purchase agreement with NHPC for setting up a 250 MW Firm and Dispatchable Renewable Energy (FDRE) project.
Capri Global reported a 99.5% year-on-year rise in net profit. Revenue increased 48.7% to ₹1,220.3 crore compared with ₹820.8 crore in the corresponding quarter last year.
Aurobindo Pharma is in focus after the Directorate General of Foreign Trade imposed a minimum import price on Pen-G, 6-APA and Amoxicillin.
JB Chemicals informed exchanges that Narayan Saraf has resigned as Chief Financial Officer, effective January 30, 2026.
Blue Star reported third-quarter results below estimates. Revenue from the Unitary Cooling Products segment declined 1% on a year-on-year basis.
Swiggy reported a wider net loss of ₹1,065 crore, compared with a loss of ₹800 crore in the year-ago period.
Manappuram Finance reported an 18% year-on-year decline in net profit. Net interest income declined 1% to ₹1,150 crore from ₹1,161 crore.
Voltas posted third-quarter results below estimates. Net profit declined 35.7% to ₹84.9 crore compared with ₹132 crore in the corresponding quarter last year.
Colgate-Palmolive India reported Q3 results in line with estimates. EBITDA declined 1.3% year-on-year to ₹448.2 crore from ₹454.4 crore.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
